Daniel Bexell Selected Research

IBL-302

1/2020	Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.
1/2019	Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Bexell Research Topics

Disease

22	Neoplasms (Cancer) 01/2023 - 01/2009
16	Neuroblastoma 01/2023 - 03/2015
7	Glioma (Gliomas) 09/2014 - 01/2009
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2020
2	Hypoxia (Hypoxemia) 01/2016 - 11/2015
2	Brain Neoplasms (Brain Tumor) 03/2012 - 07/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Necrosis 07/2019
1	Kidney Neoplasms (Kidney Cancer) 01/2015
1	Wilms Tumor (Wilm's Tumor) 11/2014

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2015
3	Interferon-gamma (Interferon, gamma)IBA 09/2014 - 07/2009
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2019
2	IBL-302IBA 01/2020 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2016
2	LigandsIBA 07/2019 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2016 - 11/2015
2	Messenger RNA (mRNA)IBA 01/2016 - 11/2015
2	enhanced green fluorescent proteinIBA 03/2012 - 01/2009
1	RNA (Ribonucleic Acid)IBA 01/2023
1	ON 01910IBA 08/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2021
1	Vincristine (Oncovin)FDA LinkGeneric 09/2020
1	Proto-Oncogene Proteins c-etsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	PT2385IBA 01/2020
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Death Domain ReceptorsIBA 07/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	N-Myc Proto-Oncogene ProteinIBA 01/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 01/2017
1	Laminin (Merosin)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	ProdrugsIBA 01/2016
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2015
1	Mechanistic Target of Rapamycin Complex 2IBA 11/2015
1	Insulin-Like PeptidesIBA 11/2015
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 03/2015
1	SynaptophysinIBA 03/2015
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2015
1	Chromogranin AIBA 03/2015
1	Therapeutic UsesIBA 06/2013
1	Interleukin-7 (Interleukin 7)IBA 01/2010
1	Glial Fibrillary Acidic ProteinIBA 07/2009
1	TubulinIBA 07/2009
1	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 07/2009
1	NestinIBA 07/2009
1	Sunitinib (Sutent)FDA Link 01/2009
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2009

Therapy/Procedure

11	Therapeutics 01/2023 - 07/2009
6	Drug Therapy (Chemotherapy) 01/2023 - 11/2014
4	Immunotherapy 11/2020 - 07/2009
1	Precision Medicine 01/2022
1	Blood Component Removal (Apheresis) 10/2021
1	Hematopoietic Stem Cell Transplantation 10/2021
1	Heterologous Transplantation (Xenotransplantation) 07/2019
1	Radiotherapy 01/2016
1	Injections 01/2009